Skip to main content

Table 1 Agreement in Metastatic Assay outcome between the development and alternative platforms

From: Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue

 

Alternative Platform (Xcel™ Array)

Assay Positive

Assay Negative

Total

Development Platform (Prostate DSA™)

Assay Positive

33

3

36

Assay Negative

1

38

39

Total

34

41

75

  1. Abbreviations: DSA = disease specific array